m+Medelevator.RU
← Поиск публикаций
Frontiers in pediatrics · 2025

Newborn clinical condition assessment using infrared thermography: correlation with the Apgar score in a prospective cohort study.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Letouzey Mathilde, Diop Samuel, Kengoum Claude Elvire Pédié, Rousseau Anne, Hot Noémie, François Juliette, Quibel Thibaud, Berveiller Paul, Boileau Pascal, Jouen François, Trabelsi Imen, Bergounioux Jean

Аннотация

OBJECTIVES: The Apgar score remains subjective in key components despite its clinical importance. An objective method using infrared thermography could enhance neonatal assessment precision. To describe early surface thermal adaptation patterns during the first 10 min after birth using infrared thermography (IRT) and to benchmark these descriptive patterns against concurrently assigned Apgar scores. This feasibility study evaluates operational characteristics of IRT as a non-contact, objective adjunct to routine assessment; it does not establish prediction or clinical utility.

STUDY DESIGN: Prospective cohort of 223 full-term cesarean-delivered newborns at a tertiary maternity hospital (2021-2023). Whole-body IRT was captured at 1, 3, 5, and 10 min after birth (T1-T10). Infants were described by Apgar at 1 min (≤7 vs. ≥8).

RESULTS: Descriptive visualizations showed observable differences in early surface temperature distributions for infants with lower Apgar scores at 1 min, with progressive warming and convergence between groups over time. Early rectal (central) temperatures in the low-Apgar group were sparsely recorded due to clinical priorities and are presented for transparency only.

CONCLUSIONS: IRT can visualize thermal adaptation during immediate neonatal transition and may serve as a non-contact, objective adjunct to clinical assessment. Further outcome-based validation in larger, more heterogeneous cohorts is needed before clinical implementation.Clinical Trial Registration: ClinicalTrials.gov, identifier NCT04483869.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты